These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34975881)

  • 1. FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations.
    Lassaunière R; Tiemessen CT
    Front Immunol; 2021; 12():788203. PubMed ID: 34975881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
    Li SS; Gilbert PB; Carpp LN; Pyo CW; Janes H; Fong Y; Shen X; Neidich SD; Goodman D; deCamp A; Cohen KW; Ferrari G; Hammer SM; Sobieszczyk ME; Mulligan MJ; Buchbinder SP; Keefer MC; DeJesus E; Novak RM; Frank I; McElrath MJ; Tomaras GD; Geraghty DE; Peng X
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31434737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.
    Cheeseman HM; Carias AM; Evans AB; Olejniczak NJ; Ziprin P; King DF; Hope TJ; Shattock RJ
    PLoS One; 2016; 11(5):e0154656. PubMed ID: 27164006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
    Forthal DN; Gach JS; Landucci G; Jez J; Strasser R; Kunert R; Steinkellner H
    J Immunol; 2010 Dec; 185(11):6876-82. PubMed ID: 21041724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination.
    Lemke MM; Theisen RM; Bozich ER; McLean MR; Lee CY; Lopez E; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Kratochvil S; Wines BD; Hogarth PM; Kent SJ; Chung AW; Arnold KB
    Front Immunol; 2022; 13():820148. PubMed ID: 35273603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.
    Li SS; Gilbert PB; Tomaras GD; Kijak G; Ferrari G; Thomas R; Pyo CW; Zolla-Pazner S; Montefiori D; Liao HX; Nabel G; Pinter A; Evans DT; Gottardo R; Dai JY; Janes H; Morris D; Fong Y; Edlefsen PT; Li F; Frahm N; Alpert MD; Prentice H; Rerks-Ngarm S; Pitisuttithum P; Kaewkungwal J; Nitayaphan S; Robb ML; O'Connell RJ; Haynes BF; Michael NL; Kim JH; McElrath MJ; Geraghty DE
    J Clin Invest; 2014 Sep; 124(9):3879-90. PubMed ID: 25105367
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Moraru M; Perez-Portilla A; Al-Akioui Sanz K; Blazquez-Moreno A; Arnaiz-Villena A; Reyburn HT; Vilches C
    Front Immunol; 2021; 12():615645. PubMed ID: 34108956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells.
    Peng X; Li SS; Gilbert PB; Geraghty DE; Katze MG
    PLoS One; 2016; 11(3):e0152425. PubMed ID: 27015273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Fc Gamma Receptor Polymorphisms Important in HIV-1 Infection Outcomes and Latent Reservoir Size?
    Lamptey H; Bonney EY; Adu B; Kyei GB
    Front Immunol; 2021; 12():656894. PubMed ID: 34017334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-retroviral antibody FcγR-mediated effector functions.
    Bournazos S; Ravetch JV
    Immunol Rev; 2017 Jan; 275(1):285-295. PubMed ID: 28133801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis.
    Wills S; Hwang KK; Liu P; Dennison SM; Tay MZ; Shen X; Pollara J; Lucas JT; Parks R; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Thomas R; Kim JH; Michael NL; Robb ML; McRaven M; Montefiori DC; Hope TJ; Liao HX; Moody MA; Ferrari G; Haynes BF; Alam SM; Bonsignori M; Tomaras GD
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.
    McLean MR; Madhavi V; Wines BD; Hogarth PM; Chung AW; Kent SJ
    J Immunol; 2017 Jul; 199(2):816-826. PubMed ID: 28615419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.
    Wines BD; Billings H; Mclean MR; Kent SJ; Hogarth PM
    Curr HIV Res; 2017; 15(3):202-215. PubMed ID: 28322167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
    Bekker LG; Moodie Z; Grunenberg N; Laher F; Tomaras GD; Cohen KW; Allen M; Malahleha M; Mngadi K; Daniels B; Innes C; Bentley C; Frahm N; Morris DE; Morris L; Mkhize NN; Montefiori DC; Sarzotti-Kelsoe M; Grant S; Yu C; Mehra VL; Pensiero MN; Phogat S; DiazGranados CA; Barnett SW; Kanesa-Thasan N; Koutsoukos M; Michael NL; Robb ML; Kublin JG; Gilbert PB; Corey L; Gray GE; McElrath MJ;
    Lancet HIV; 2018 Jul; 5(7):e366-e378. PubMed ID: 29898870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HIV Vaccine Protective Allele in
    Ebonwu J; Lassaunière R; Paximadis M; Goosen M; Strehlau R; Gray GE; Kuhn L; Tiemessen CT
    Front Immunol; 2021; 12():760571. PubMed ID: 34917081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability at the FCGR locus: characterization in Black South Africans and evidence for ethnic variation in and out of Africa.
    Lassaunière R; Tiemessen CT
    Genes Immun; 2016 Mar; 17(2):93-104. PubMed ID: 26673965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.
    Lassaunière R; Musekiwa A; Gray GE; Kuhn L; Tiemessen CT
    Retrovirology; 2016 Jun; 13(1):40. PubMed ID: 27287460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression.
    Connolly S; Wall KM; Tang J; Yu T; Kilembe W; Kijak G; Allen S; Hunter E
    Virology; 2018 Dec; 525():132-142. PubMed ID: 30278383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.
    Gottardo R; Bailer RT; Korber BT; Gnanakaran S; Phillips J; Shen X; Tomaras GD; Turk E; Imholte G; Eckler L; Wenschuh H; Zerweck J; Greene K; Gao H; Berman PW; Francis D; Sinangil F; Lee C; Nitayaphan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Tartaglia J; Robb ML; Michael NL; Kim JH; Zolla-Pazner S; Haynes BF; Mascola JR; Self S; Gilbert P; Montefiori DC
    PLoS One; 2013; 8(9):e75665. PubMed ID: 24086607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.